Apr 09 (Reuters) - Neogen Q3 revenue USD 221 million vs. IBES estimate USD 224.9 million.
- Q3 adjusted net income USD 20.9 million
- Q3 net income USD -11 million
- outlook FY revenue USD 895 million
- outlook FY adjusted EBITDA USD 195 million
Apr 09 (Reuters) - Neogen Q3 revenue USD 221 million vs. IBES estimate USD 224.9 million.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.